BRCA2 and ovarian carcinoma: Furthermore, this study demonstrated that patients with two inherited pathogenic variants were more likely to develop ovarian cancer compared with those with a BRCA2 pathogenic variant alone (16.9 vs. 9.3%, p = 0.0017) [25].